Lovastatin:
(1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-Hydroxy-6-oxooxan-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-methylbutanoate ; CAS : 75330-75-5 ; C24H36O5 ; MW: 404.54 ; |
Lovastatin Impurity A:
(1S,7S,8S,8aR)-8-{2-[(2R,4R)-4-Hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-methylbutanoate ; CAS : 73573-88-3 ; C23H34O5 ; MW: 390.51 ; |
Lovastatin Impurity B:
(3R,5R)-7-[(1S,2S,6R,8S,8aR)-2,6-dimethyl-8-[[(2S)-2-methylbutanoyl]oxy]-1,2,6,7, 8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid sodium salt ; CAS : 75225-50-2 ; C24H37NaO6 ; MW: 444.54 ; |
Lovastatin Impurity C:
(2S)-2-Methylbutanoic Acid (1S,3R,7S,8S,8aR)-8-[2-[(2R)-3,6-Dihydro-6-oxo-2H-pyran-2-yl]ethyl]-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-1-naphthalenyl Ester ; CAS : 109273-98-5 ; C24H34O4 ; MW: 386.52 ; |
Lovastatin Impurity D:
(2R,4R)-2-[2-[(1S,2S,6R,8S,8aR)-2,6-Dimethyl-8-[[(2S)-2-methylbutanoyl]oxy]-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]ethyl]-6-oxotetrahydro-2H-pyran-4-yl (3R,5R)-7-[(1S,2S,6R,8S,8aR)-2,6-dimethyl-8-[[(2S)-2-methylbutanoyl]oxy]-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoate ; CAS : 149756-62-7 ; C48H72O10 ; MW: 809.08 ; |
Lovastatin Impurity E:
Butanoic acid, 2-methyl-, 1,2,3,4,4a,7,8,8a-octahydro-3,7-dimethyl-8-(2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester, (1S-(1-alpha (R*), 3-alpha, 4a-alpha, 7-beta, 8-beta (2S*,4S*), 8a-beta)) ; CAS : 77517-29-4 ; C24H38O5 ; MW: 406.56 ; |
Lovastatin Impurity F:
(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-Hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8ahexahydronaphthalen-1-yl (2Z)-2-methylbut-2-enoate ; C24H34O5 ; MW: 402.52 ; |